Main content
Sorry, this episode is not currently available

First malaria vaccine approved for widespread use

Professor Sir Brian Greenwood and Thomas Breuer discuss the breakthrough.

The disease malaria causes widespread misery, especially across Africa. A vaccine developed in the UK by pharmaceutical company GSK has become the first to be approved for large-scale use. Justin Webb speaks to Professor Sir Brian Greenwood who has played a key role in the vaccine鈥檚 development and Thomas Breuer who is the Chief Global Health Officer at GSK.

Credit: Getty Images

Release date:

6 minutes

Podcast